Notably, Pfizer's Comirnaty COVID vaccine is still approved or authorized for people 6 months of age and older without any restrictions based on risk factors for COVID — at least for now. But the FDA ...

With vaccine revenue crumbling and layoffs in full swing, is Moderna’s slimmed-down strategy a smart move or a red flag for ...

The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Moderna's stock fell Wednesday after Health and Human Services Secretary Robert F. Kennedy Jr. said the department was winding down development of mRNA vaccines.

The US Health Secretary has stopped about $500m worth of funding for the development of vaccines against viruses that cause illnesses like flu and Covid-19. Robert F. Kennedy - a vaccine sceptic - ...

This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...

The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...